Motion sickness is a prevalent condition affecting approximately one in three people globally. Traditionally viewed merely as a reaction to certain types of motion, recent studies have begun to uncover its more complex physiological underpinnings, revealing connections to metabolic regulation and potential pathways for obesity treatment.
A collaborative study by researchers at Baylor College of Medicine, the University of Texas Health Science Centre at Houston, and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital has identified critical brain circuits involved in motion sickness. Published in Nature Metabolism, this research highlights how these circuits also play significant roles in temperature regulation and metabolic balance.
The Role of Brain Circuits
The study focused on the medial vestibular nucleus parvocellular glutamatergic neurons (MVePCGlu), which were found to become active during episodes of motion sickness. This activation is linked to hypothermia—a drop in body temperature—exhibited by mice subjected to motion-inducing stimuli. Notably, these mice demonstrate changes such as increased physical activity but maintain less weight gain, improved glucose tolerance, and heightened insulin sensitivity despite higher food intake.
Experimental Methodology
Utilizing a mouse model, researchers measured physiological responses, including core body temperature and brain activity, in response to controlled motion stimuli. While human symptoms like vomiting could not be replicated in mice, the observations made during the experiments provided a valuable perspective on how motion sickness might influence metabolic processes.
Implications for Obesity Treatment
The implications of this study are profound, particularly concerning obesity. The inhibition of MVePCGlu neurons led to an increase in body temperature and energy expenditure, which suggests a novel pathway for treating obesity. By better understanding the vestibular system’s link to metabolic regulation, researchers propose that targeting this brain circuit could yield innovative treatments aimed at managing weight and metabolic disorders.
-Raja Aditya
